Mario Maas

Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention

Rolf G. Boot, Marri Verhoek, Maaike de Fost et al. · Blood · 2003 · 338 citations · Full text

Life Sciences, Immunology, Pathology +15

Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response

Nick Dekker, Laura van Dussen, Carla E. M. Hollak et al. · Blood · 2011 · 290 citations

Life Sciences, Biochemistry, Molecular Medicine +12

METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII

Burak Koçak, Tugba Akinci D’Antonoli, Nathaniel D. Mercaldo et al. · Insights into Imaging · 2024 · 269 citations · Full text

Management, Radiology, Diagnostic Radiology +16

Sustained therapeutic effects of oral miglustat (Zavesca, <i>N</i>‐butyldeoxynojirimycin, OGT 918) in type I Gaucher disease

Deborah Elstein, Carla E. M. Hollak, Johannes M. F. G. Aerts et al. · Journal of Inherited Metabolic Disease · 2004 · 233 citations

Pharmacy, Pharmacotherapy, Neurobiology Of Disease +3

Measuring hindfoot alignment radiographically: the long axial view is more reliable than the hindfoot alignment view

Mikel L. Reilingh, Lijkele Beimers, Gabriëlle J. M. Tuijthof et al. · Skeletal Radiology · 2010 · 215 citations · Full text

Health Professions, Orthopaedic Surgery, Orthopedic Surgery +10